Trials / Completed
CompletedNCT00480805
HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)
HYZAAR Versus Ramipril Diabetic Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 312 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study to test the safety and efficacy of HYZAAR as compared to Ramipril in patients with type 2 diabetes mellitus (high blood sugar) and hypertension (high blood pressure).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0954A, losartan potassium (+) hydrochlorothiazide (HYZAAR) / Duration of Treatment : 8 Weeks | |
| DRUG | Comparator : ramipril /Duration of Treatment : 8 Weeks |
Timeline
- Start date
- 2001-08-08
- Primary completion
- 2002-10-15
- Completion
- 2002-10-16
- First posted
- 2007-05-31
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00480805. Inclusion in this directory is not an endorsement.